Atticus Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Buy
1,664
+9
+0.5% +$9.2K 0.48% 43
2026
Q1
$1.52M Sell
1,655
-17
-1% -$17.2K 0.41% 44
2025
Q4
$1.8M Sell
1,672
-4
-0.2% -$3.83K 0.44% 41
2025
Q3
$1.28M Sell
1,676
-31
-2% -$23.1K 0.32% 50
2025
Q2
$1.33M Buy
1,707
+58
+4% +$45.1K 0.36% 42
2025
Q1
$1.36M Buy
1,649
+59
+4% +$49.1K 0.44% 37
2024
Q4
$1.23M Sell
1,590
-24
-1% -$19.9K 0.38% 37
2024
Q3
$1.43M Buy
1,614
+16
+1% +$14.4K 0.46% 35
2024
Q2
$1.45M Sell
1,598
-60
-4% -$48K 0.47% 33
2024
Q1
$1.29M Sell
1,658
-49
-3% -$34.9K 0.42% 34
2023
Q4
$995K Sell
1,707
-135
-7% -$78.8K 0.35% 40
2023
Q3
$989K Hold
1,842
0.38% 38
2023
Q2
$864K Buy
1,842
+32
+2% +$13.4K 0.32% 44
2023
Q1
$622K Sell
1,810
-160
-8% -$54K 0.24% 65
2022
Q4
$721K Sell
1,970
-21
-1% -$7.45K 0.3% 61
2022
Q3
$645K Hold
1,991
0.31% 46
2022
Q2
$645K Buy
1,991
+97
+5% +$29.1K 0.27% 58
2022
Q1
$543K Buy
1,894
+15
+0.8% +$3.86K 0.2% 79
2021
Q4
$519K Buy
1,879
+1
+0.1% +$254 0.2% 68
2021
Q3
$434K Sell
1,878
-66
-3% -$16.3K 0.19% 64
2021
Q2
$446K Sell
1,944
-199
-9% -$40K 0.19% 69
2021
Q1
$400K Sell
2,143
-147
-6% -$28.8K 0.19% 72
2020
Q4
$387K Buy
2,290
+1
+0% +$149 0.19% 68
2020
Q3
$339K Buy
2,289
+1
+0% +$155 0.2% 64
2020
Q2
$376K Buy
2,288
+1
+0% +$153 0.25% 61
2020
Q1
$317K Hold
2,287
0.26% 60
2019
Q4
$301K Buy
+2,287
New +$265K 0.19% 67

Other funds holding LLY

Atticus Wealth Management's LLY Position: Q2 2026 in Review

Atticus Wealth Management increased its Eli Lilly (LLY) stake by 0.54% in Q2 2026, buying an estimated $9.2K and bringing the position to 1,664 shares worth $2M. The position accounts for 0.48% of the portfolio, ranked #43.

Atticus Wealth Management first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Atticus Wealth Management held 1,664 shares of Eli Lilly worth $2M as of Q2 2026.
  • Atticus Wealth Management bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.48% of Atticus Wealth Management's portfolio in Q2 2026, its #43 holding.
  • Atticus Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Atticus Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.